CYP3A4*22 May Increase Bleeding Risk in Ticagrelor Users

Hilkka Liedes*, Juha Pajula, Anna‐Leena Vuorinen, Francesco De pretis, Mark Van gils, Kari Harno, Mika Lehto, Mikko Niemi, Jaakko Lähteenmäki

*Corresponding author for this work

Research output: Contribution to journalArticleScientificpeer-review

4 Citations (Scopus)
63 Downloads (Pure)
Original languageEnglish
Pages (from-to)202-207
JournalBasic and Clinical Pharmacology and Toxicology
Volume133
Issue number2
DOIs
Publication statusPublished - Aug 2023
MoE publication typeA1 Journal article-refereed

Keywords

  • adverse drug events
  • antiplatelet drugs
  • ischemic heart disease
  • pharmacogenetics
  • polymorphism
  • precision medicine

Cite this